CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Low cost and time for novel drug discovery and significant technological
upgradations
4.1.2. Growing biotechnology and biopharmaceutical industries
4.1.3. Increasing incidence of cancer
4.1.4. Corporate & government funding for cell-based research
4.1.5. Increasing focus on personalized medicine
4.2. Market Restraints & Challenges
4.2.1. Lengthy approval procedures
4.2.2. Lack of skilled professionals
4.2.3. The high cost of cell analysis systems
4.3. Market Opportunities
4.3.1. Increasing preference of contract research organizations which offers high content
screening services
4.3.2. Automation in cancer research
4.3.3. Emerging markets
CHAPTER 5 GLOBAL CELL ANALYSIS MARKET – BY PRODUCT
5.1. Consumables
5.1.1. Reagents
5.1.2. Assay Kits
5.1.2.1. Immunoassays
5.1.2.2. Cell-Based Assays
5.1.3. Microplates
5.1.4. Other Consumables
5.2. Instruments
5.2.1. Microscopes
5.2.1.1. Electron Microscopes
5.2.1.2. Inverted Microscopes
5.2.1.3. Stereo Microscopes
5.2.1.4. Fluorescence and Confocal Microscopes
5.2.1.5. Phase Contrast Microscopes
5.2.1.6. Near-Field Scanning Optical Microscopes (NSOM)
5.2.1.7. Other Microscopes
5.2.2. Flow Cytometry
5.2.2.1. Flow Cytometry Instruments
5.2.2.2. Flow Cytometry Software
5.2.3. Spectrophotometers
5.2.3.1. Fluorescence Microplate Readers
5.2.3.2. Colorimeters
5.2.3.3. Microplate Spectrophotometers
5.2.4. QPCR
5.2.5. Cell Counters
5.2.5.1. Automated Cell Counters
5.2.5.2. Hem cytometers and Manual Cell Counters
5.2.6. High-Content Screening (HCS) Systems
5.2.6.1. Cell Imaging and Analysis HCS Systems
5.2.6.2. HCS Software
5.2.7. Cell Microarrays
CHAPTER 6 GLOBAL CELL ANALYSIS MARKET – BY PROCESS
6.1. Cell Interaction
6.2. Cell Viability
6.3. Cell Signaling Pathways/Signal Transduction
6.4. Cell Proliferation
6.5. Cell Counting and Quality Control
6.6. Cell Identification
6.7. Cell Structure Study
6.8. Target Identification and Validation
6.9. Single-Cell Analysis
CHAPTER 7 GLOBAL CELL ANALYSIS MARKET – BY END USER
7.1. Hospitals and Academic & Research Institutes
7.2. Laboratories
7.3. Contract Research Organizations and Pharmaceutical & Biotechnology Companies
7.4. Cell Culture Collection Repositories
CHAPTER 8 GLOBAL CELL ANALYSIS MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9 GLOBAL CELL ANALYSIS MARKET - COMPANY PROFILES
9.1. Promega Corporation
9.2. Merck KgaA
9.3. Thermo Fisher Scientific, Inc.
9.4. Danaher Corporation
9.5. GE Healthcare
9.6. Agilent Technologies, Inc.
9.7. Olympus Corporation
9.8. Perkinelmer, Inc.
9.9. Becton, Dickinson and Company
9.10. Tecan Group Ltd.
9.11. Beckman Coulter, Inc.
9.12. Bio-Rad Laboratories, Inc.
9.13. Illumina, Inc.
9.14. Qiagen N.V.
9.15. PerkinElmer, Inc.
CHAPTER 10 GLOBAL CELL ANALYSIS MARKET - COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11 MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12 APPENDIX
12.1. List of Tables
12.2. List of Figures
